on ABILIFY Tablets (15 mg/day or 30 mg/day as monotherapy with a abilify information dose of 30 mg/day) for at least 6 abilify information weeks and then randomized to ABILIFY abilify information abilify information mg/day or 30 mg/day) or placebo and monitored for relapse, demonstrated abilify information benefit of such maintenance treatment [see abilify information Studies]. While it is generally.

mg/day or abilify information abilify information administered on a once-a-day abilify information without regard to abilify information abilify information has been systematically abilify information and abilify information to be effective in a dose range of 10 mg/day to 30 abilify information when administered as the tablet formulation; abilify information abilify information higher abilify information 10 mg/day or 15 abilify information were not abilify information effective than 10 mg/day or abilify information mg/day. Dosage increases should not be made before 2 weeks, abilify information time needed to achieve steady-state [see Clinical Studies].AdolescentsThe recommended abilify information dose of ABILIFY is 10 abilify information Aripiprazole abilify information studied in pediatric patients 13 to 17 years of age with Schizophrenia at abilify information doses of 10 mg and 30 mg. The starting daily dose of the tablet formulation in these patients was 2 mg, abilify information was titrated to 5 mg after 2 days and to the target dose of 10 mg after 2 additional days. abilify information abilify information increases should be administered abilify information 5 mg increments. The 30 mg/day dose was not shown abilify information be more efficacious abilify information the 10 mg/day abilify information ABILIFY can be administered without regard to meals [see Clinical.

for ABILIFY® (aripiprazole)INDICATIONS: ABILIFY is indicated abilify information treatment to antidepressants for major abilify information disorder major.